Regis Cebe

Title: Innovations and Contributions of Inventor Regis Cebe

Introduction

Regis Cebe is a notable inventor based in Saint-Louis, France. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules and therapeutic methods. With a total of 6 patents to his name, Cebe's work has the potential to impact various medical treatments.

Latest Patents

Cebe's latest patents include groundbreaking innovations such as CD19 binding molecules and their uses. This patent provides detailed information on CD19 binding molecules that specifically target CD19, including monospecific, bispecific, and trispecific binding molecules. The patent also covers conjugates that incorporate these binding molecules and pharmaceutical compositions that utilize them. Furthermore, it outlines methods for using CD19 binding molecules to treat diseases associated with CD19 expression. Another significant patent relates to methods of treating FGF21-associated disorders, which involves monoclonal antibodies and antigen-binding fragments that bind to human β-klotho, along with related pharmaceutical compositions and treatment methods.

Career Highlights

Regis Cebe is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in the pharmaceutical industry. Cebe's research and inventions have contributed to advancements in therapeutic approaches, particularly in oncology and metabolic disorders.

Collaborations

Cebe has collaborated with esteemed colleagues such as David Langdon Yowe and Stephane Olland. These collaborations have fostered a productive environment for innovation and have led to the development of impactful medical solutions.

Conclusion

Regis Cebe's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and therapeutic methods.